Why is Strides Pharma falling/rising?

As of 03-Nov, Strides Pharma Science Ltd's stock price is rising, currently at Rs 982.00, reflecting an increase of Rs 46.4 or 4.96%. The stock has recently reached a new 52-week high of Rs 1024.9 and has outperformed its sector by 3.66%. Over the last two days, it has gained 15.54%, and its performance over the past week shows a remarkable increase of 20.71%. The company has demonstrated consistent positive results, with operating profit to interest at its highest and a strong PBDIT, despite a decline in profits over the past year. The stock is trading at a discount compared to its peers, contributing to its attractive valuation and recent upward movement.
In the broader market context, while Strides Pharma has shown significant short-term gains, the benchmark Sensex has experienced a decline of 0.94% over the past week. This stark contrast highlights the stock's strong performance relative to the market. Additionally, the stock's year-to-date return of 49.33% significantly outpaces the Sensex's 7.47%, indicating robust investor confidence and participation, as evidenced by a substantial increase in delivery volume. Overall, the combination of strong financial results, attractive valuation, and positive market sentiment has driven the stock's recent rise.